Tejnaksh Healthcare Gains 9.50%: 3 Key Factors Driving the Weekly Move
2026-11-21 14:02:23Key Events This Week 16 Nov: Upgrade to Sell rating on technical and valuation improvements 17 Nov: Valuation shifts to fair amid mixed market performance 18 Nov: Downgrade to Strong Sell amid technical and financial concerns 20 Nov: Week closes at Rs.15.10 (+9.50%) outperforming Sensex Week OpenRs.13.79 Week Close<di...
Read More
Tejnaksh Healthcare Ltd Upgraded to Sell on Technical and Valuation Improvements
2026-11-16 08:31:24Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook and valuation metrics despite ongoing fundamental challenges. The healthcare services company’s recent performance and market data reveal a complex picture of sideways technical trends, fair valuation adjustments, and flat financial results that have influenced this reassessment.
Read More
Tejnaksh Healthcare Ltd Valuation Shifts to Fair Amid Mixed Market Performance
2026-11-16 08:01:55Tejnaksh Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions and sector dynamics. Despite a recent uptick in share price, the company’s micro-cap status and subdued financial metrics continue to weigh on investor sentiment.
Read More
Tejnaksh Healthcare Ltd Valuation Shifts Signal Heightened Price Attractiveness Amid Market Challenges
2026-10-23 08:02:34Tejnaksh Healthcare Ltd has seen a marked improvement in its valuation parameters, shifting from an attractive to a very attractive price level, despite ongoing challenges reflected in its share price performance and financial returns. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), comparing them with historical trends and peer benchmarks to assess the stock’s price attractiveness and investment potential.
Read MoreSubmission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2026.
12-Nov-2026 | Source : BSEPlease find enclosed unaudited financial result for half year ended Sep 26
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And
12-Nov-2026 | Source : BSEBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window
07-Nov-2026 | Source : BSETejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 12th Nov 2026 to transact the business as given below:
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Tejnaksh Healthcare Ltd has announced 5:10 stock split, ex-date: 19 Jul 23
Tejnaksh Healthcare Ltd has announced 36:10 bonus issue, ex-date: 26 Apr 18
No Rights history available